Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Merck Stories

2013-12-12 08:31:32

Supply and License Agreement Amended and Extended through 2023 LOVELAND, Colo., Dec. 12, 2013 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider of veterinary diagnostic and specialty products, announced today that it has amended and extended its Supply and License Agreement with Merck Animal Health related to the supply of Heska's canine heartworm preventive. Merck Animal Health has the exclusive right to market and sell Heska's canine...

2013-12-10 23:02:10

The firm is actively filing Fosamax lawsuits on behalf of those who allegedly suffered femur fractures, necrosis of the jaw and other serious complications related to their use of the drug. (PRWEB) December 10, 2013 Drugmaker Merck announced on Dec. 9 that it has agreed to pay about $28 million to settle Fosamax lawsuits stemming from claims that the osteoporosis drug caused patients’ jaws to deteriorate, or even “die,” according to Reuters. The Rottenstein Law Group LLP notes that...

2013-12-05 20:22:17

NEW YORK, Dec. 5, 2013 /PRNewswire/ -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased ARIAD Pharmaceuticals, Inc. ("ARIAD" or the "Company") (NASDAQ GS: ARIA) stock between December 12, 2011 and October 8, 2013. The Complaint alleges that throughout the Class Period defendants made false and misleading statements regarding the safety and efficacy of...

2013-12-04 23:02:58

Reportbuyer.com just published a new market research report: Vaniprevir (Hepatitis C Virus) - Forecast and Market Analysis to 2022. London (PRWEB) December 04, 2013 Vaniprevir (Hepatitis C Virus) - Forecast and Market Analysis to 2022 Summary Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint pain, itchy skin or jaundice. There is no...

2013-12-04 12:24:49

DUBLIN, December 4, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/9n9pzh/orphan_drugs) has announced the addition of the "Orphan Drugs - Global Strategic Business Report" [http://www.researchandmarkets.com/research/9n9pzh/orphan_drugs ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report analyzes the worldwide markets for Orphan Drugs...

2013-12-03 16:25:34

DUBLIN, December 3, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/67g6vc/global) has announced the addition of the "Global Genitourinary Drugs Market 2011-2015" [http://www.researchandmarkets.com/research/67g6vc/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) TechNavio's analysts forecast the Global Genitourinary Drugs market to grow at a CAGR of 3.05 percent over the period...

2013-12-02 23:03:56

Wellframe, a Boston-based company that combines mobile devices and artificial intelligence to amplify therapeutic relationships in order to engage patients in personalized care plans, today announced that the organization has been selected as a semi-finalist for the Merck | Heritage Provider Network Innovation Challenge. Boston, MA (PRWEB) December 02, 2013 Wellframe, a Boston-based company that combines mobile devices and artificial intelligence to amplify therapeutic relationships in...

2013-12-02 16:23:28

John Daly, former Merck Executive, begins CTW consulting, offering expert frontline coaching, leadership development and pharmaceutical industry expertise to corporations such as IMS Health. NEW YORK, Dec. 2, 2013 /PRNewswire-iReach/ -- Former Merck executive, John Daly, recently founded CTW with two primary missions. (Photo: http://photos.prnewswire.com/prnh/20131202/MN25895) The first is to offer pharmaceutical industry consulting services to corporations such as IMS Health....

2013-11-25 08:27:33

Every Pledge on ProjectIDesign.com Will Reveal a Piece of a New, Community-Created Design WHITEHOUSE STATION, N.J., Nov. 25, 2013 /PRNewswire/ -- To commemorate World AIDS Day 2013, Merck (NYSE: MRK), known as MSD outside the United States and Canada, is encouraging people impacted by HIV to take action with the educational HIV campaign, I Design. Starting today, visitors to www.ProjectIDesign.com can mark the day by making a pledge to learn more about HIV, educate someone else about...

2013-11-20 08:28:43

NEW YORK, November 20, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom Today, Analysts' Corner announced new research reports highlighting Cell Therapeutics, Inc. (NASDAQ: CTIC), Akorn, Inc. (NASDAQ: AKRX), Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), and Ariad Pharmaceuticals Inc. (NASDAQ: ARIA). Today's readers may access these reports free of charge - including...